http://mobile.abc.net.au/news/2015-07-15/biotechnology-startups-grapple-with-risk-shy-market/6623164
Limited government support and a market shy of backing risky investments has forced a Western Australian company aiming to revolutionise cancer treatment to look offshore to find funds.
Perth-based biotechnology firm Phylogica has spent 15 years working on a treatment that would essentially kill off cancer cells by stopping them from dividing.
"They didn't look offshore to bite us "
lol kind of
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.055(4.23%) |
Mkt cap ! $726.1M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.24 | $173.1K | 139.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33352 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 7691 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |